Decision weakens a separate probe by a Milan prosecutor into hedge fund’s sale to RedBird
Activist investor wants CEO replaced, but turnaround remains at mercy of plane maker
Activist fund reveals a $1.9bn stake in the low-cost carrier and cites ‘unacceptable’ performance
Plus, De Beers unveils plan to counter lab-grown diamonds and the cloud-computing company riding Nvidia’s coattails
US activist investor wants share price to reflect $180bn value of Japanese tech conglomerate’s investments
Non-real estate companies recorded big increase in property book values in 2023, according to Goldman Sachs
US manager known for aggressive approach bets markets are too pessimistic about potential losses on utility’s debt
Plus, Elliott’s caught in an AC Milan legal battle and Byju’s investors try to oust its founder
US firm is battling former Italian partners, prosecutors and police over €1.2bn sale of football club in 2022
US activist’s interest comes as London-listed SMIT has fallen out of favour
Lawsuit in Crown Castle/Elliott case highlights how other parties are taking an interest in fine print of settlements
Investigation into potential irregularities over 2022 deal between Elliott Management and private equity group RedBird
US investment firm says board of high street group has failed to engage with it
Plus, the money behind The Body Shop’s rescue and the Shakespearean drama of an Italian dynasty
Paul Best is leading the US hedge fund’s bid for Currys in an attempt to boost its retail portfolio
Co-founder of telecoms group Crown Castle criticises agreement to offer board seat to powerful hedge fund
UK electronics retailer says 67p a share offer still ‘significantly’ undervalues it and future prospects
Florida firm’s new Hyperion venture to be led by former Newcrest chief executive
Redwheel says they are ‘in complete agreement’ that business is worth substantially more than Elliott’s offer
Interest comes days after UK electronics retailer rejected unsolicited bid from Elliott Management
Currys shares are down a third in the past year but its board said the bid undervalued the company
Plus, Novo Nordisk’s complex deal and Elliott’s next Japanese target
US investor calls on Mitsui Fudosan to stage ¥1tn buyback and sell stake in company behind Tokyo Disneyland
Paul Singer’s firm calls for new blood to fix ‘underperformance’ as it reveals $1bn stake
No deal was reached with hedge fund after efforts to secure more than €400mn of financing
UK Edition
